- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
DVLA
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Darya-Varia Laboratoria Tbk · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
1,585 IDR
-0.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.2% above the Trend Line and sits at 56.9% of its 52-week range. The latest completed week returned -0.9%, after a 2.6% four-week move. The latest news-sentiment score is 50/100.
Setup score
59
out of 100
Latest Close
1,585 IDR
7 Aug 2026
1W Return
-0.9%
latest completed week
4W Return
2.6%
short-term follow-through
12W Return
3.2%
quarterly tape
Trend Breadth
57.7%
30 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 41.92% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.9%
Latest completed week; four-week move 2.6%.
Indicator stack
32/81
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.92%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.2% above the Trend Line and sits at 56.9% of its 52-week range. The latest completed week returned -0.9%, after a 2.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3012-week average 0.24
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.30Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.6% over four weeks, 3.2% over 12 weeks, and -1.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year30
Trend breadth57.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.80Latest activity-pressure read.
Pressure change210.7%Four-week change in activity pressure.
Leadership15.03Latest relative-leadership reading.
RS change-34.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.5%Distance below the 52-week high.
13-week volatility2.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2613 weeks finished lower.
Best week+3.6%Week of 19 Jun.
Worst week-5.4%Week of 5 Jun.
Latest week-0.9%Week of 7 Aug.
Shape of recent returns
Strong gains0
Modest gains10
Flat weeks3
Modest losses12
Sharp losses1
Recent vol2.1%13-week weekly-return volatility.
Base vol1.7%52-week weekly-return volatility.
Up/down split22/21Count of positive and negative weeks in the 52-week window.
Average skew1.3% / -1.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank23 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Drug Manufacturers - Specialty & Generic
4-week rank4 / 4
Group average5.5%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD50.0%positive activity pressure
RS75.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape57/100
Trend, activity pressure, participation, and risk combine to a 57/100 tape read.
Indicator analysis36/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 12/12.
Activity pressure 0.30; No reversal markers Next-Week ExpectancyNegative 41.92%Next-week expectancy is negative with a 41.92% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
PT Darya-Varia Laboratoria Tbk Revenue Breakdown – IDX:DVLA Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,585 IDR | -0.9% | 1,583 IDR | 1,538 IDR | 0.80 | 15.03 | 70.0K | Off |
| 31 Jul 2026 | 1,600 IDR | 1.3% | 1,585 IDR | 1,539 IDR | 0.51 | 19.71 | 85.0K | Off |
| 24 Jul 2026 | 1,580 IDR | 1.3% | 1,587 IDR | 1,540 IDR | -0.01 | 19.39 | 80.9K | Off |
| 17 Jul 2026 | 1,560 IDR | 1.0% | 1,589 IDR | 1,541 IDR | -0.43 | 18.68 | 15.0K | Off |
| 10 Jul 2026 | 1,545 IDR | 2.3% | 1,593 IDR | 1,541 IDR | -0.72 | 22.82 | 38.0K | Off |
| 3 Jul 2026 | 1,510 IDR | -1.4% | 1,596 IDR | 1,542 IDR | -1.11 | 21.38 | 10.7K | Off |
| 26 Jun 2026 | 1,531 IDR | 0.6% | 1,601 IDR | 1,543 IDR | -1.32 | 22.99 | 26.0K | Off |
| 19 Jun 2026 | 1,521 IDR | 3.6% | 1,605 IDR | 1,543 IDR | -1.57 | 16.99 | 10.8K | Off |
| 12 Jun 2026 | 1,469 IDR | 2.0% | 1,610 IDR | 1,544 IDR | -1.72 | 16.28 | 11.0K | Off |
| 5 Jun 2026 | 1,440 IDR | -5.4% | 1,616 IDR | 1,545 IDR | -1.72 | 22.65 | 29.4K | Off |
| 29 May 2026 | 1,521 IDR | -0.3% | 1,623 IDR | 1,546 IDR | -1.69 | 18.70 | 36.3K | Off |
| 22 May 2026 | 1,526 IDR | -0.6% | 1,627 IDR | 1,547 IDR | -1.69 | 18.69 | 102.6K | Off |
| 15 May 2026 | 1,536 IDR | -0.6% | 1,632 IDR | 1,547 IDR | -1.58 | 9.75 | 67.3K | Off |
| 8 May 2026 | 1,545 IDR | 0.3% | 1,632 IDR | 1,547 IDR | -1.48 | 6.61 | 109.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.